It was a busy week in Boston tech. Here’s a recap of some of the latest headlines:
—GE Healthcare and Partners HealthCare announced a 10-year partnership to develop artificial intelligence tools to improve healthcare. The collaboration will initially focus on applying... Read more »
After beta testing technology that provides remote assistant services for the blind, San Diego-based Aira has raised $12 million in a Series B round that it says will enable the company to expand its service to thousands of visually impaired users... Read more »
Finding a healthcare company with the right technological know-how can be an attractive investment opportunity. That’s the thinking behind a move announced this morning by activist investor Elliott Associates, which bought a 9.2 percent stake in Boston-area health IT company Athenahealth... Read more »
Biobot Labs, a startup that aims to help governments address the opioid crisis by analyzing sewage samples to understand drug consumption trends, won first place Wednesday night at a demo event for the inaugural session of MIT’s DesignX startup accelerator... Read more »
Chris Garabedian, a veteran biotech executive who helped turn Sarepeta Therapeutics around before his controversial exit in 2015, has returned to the life sciences scene—this time with a new venture to form some biotech startups and help others find their footing.... Read more »
General Electric’s venture capital arm has invested an undisclosed amount in Tamr, the “data unification” software firm based in Cambridge, MA.
Boston-based GE (NYSE: GE) tapped Tamr in 2014 to help it unify and clean up data from more than... Read more »
The Boundless boys are at it again. Ariel Diaz and Aaron White, who previously co-founded Boston education startup Boundless, have moved to New York City to pursue a new tech venture.
The new company is called Blissfully, and it recently... Read more »
[Updated 5/17/17, 4:53 pm. See below.] Iboss, a San Diego-based cybersecurity firm that opened a small satellite office in Boston last year, has expanded its presence in Massachusetts and decided to designate the local outpost as its corporate... Read more »
Drug pricing. The opioid epidemic. Boardroom diversity. Immigration crackdowns. The state of cancer care now, and in the future. These things aren’t just topics of conversation in Boston biotech circles, but nationwide. Connecting those two with some lively, candid discussions was... Read more »